RT @CochraneJapan: 多発性硬化症がある人の状態の変化(評価項目)を予測するためにどのようなモデルがあるか? https://t.co/PaxMnhYeOw
RT @CochraneJapan: 多発性硬化症がある人の状態の変化(評価項目)を予測するためにどのようなモデルがあるか? https://t.co/PaxMnhYeOw
多発性硬化症がある人の状態の変化(評価項目)を予測するためにどのようなモデルがあるか? https://t.co/PaxMnhYeOw
RT @CochraneJapan: 多発性硬化症がある人の結果(評価項目)を予測するためにどのようなモデルがあるか? https://t.co/JenwDcVgFf
多発性硬化症がある人の結果(評価項目)を予測するためにどのようなモデルがあるか? https://t.co/JenwDcVgFf
Are prognostic prediction models reliable for people planning for care in those suffering from multiple sclerosis https://t.co/zpQ8iYC0G5 https://t.co/Lcqi6LcFbU
RT @KelDoesBiostats: New work on clinical prediction models: https://t.co/gYY5vJVPLP Some take aways: (1) Models are not ready for clinical…
RT @NeuroVisionLab: What an intense & long journey to our #CochraneReview @cochranecollab! It was worth it!🥳Irmak @KelDoesBiostats @ulrike_…
RT @KelDoesBiostats: New work on clinical prediction models: https://t.co/gYY5vJVPLP Some take aways: (1) Models are not ready for clinical…
What an intense & long journey to our #CochraneReview @cochranecollab! It was worth it!🥳Irmak @KelDoesBiostats @ulrike_held @HeidiBaya et al. reviewed prognostic models for predicting #multiplesclerosis All for developing personalized therapy approache
New work on clinical prediction models: https://t.co/gYY5vJVPLP Some take aways: (1) Models are not ready for clinical use, (2) Most do not appear to be meant for use, (3) There is a disconnect between methods research and clinical research @ulrike_held @H